Name | Number of supported studies  | Average coverage | |
|---|---|---|---|
| fibroblast | 43 studies | 54% ± 23% | |
| pericyte | 19 studies | 42% ± 17% | |
| connective tissue cell | 17 studies | 58% ± 20% | |
| smooth muscle cell | 12 studies | 29% ± 15% | |
| myofibroblast cell | 10 studies | 43% ± 14% | |
| mesothelial cell | 5 studies | 38% ± 12% | |
| adventitial cell | 4 studies | 64% ± 14% | |
| endothelial cell | 3 studies | 24% ± 4% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
|---|---|---|---|---|---|---|
| breast | 99% | 6447.55 | 455 / 459 | 97% | 83.23 | 1088 / 1118 |
| prostate | 100% | 4934.09 | 245 / 245 | 94% | 35.34 | 474 / 502 |
| lung | 99% | 5889.91 | 573 / 578 | 94% | 55.97 | 1085 / 1155 |
| ovary | 100% | 4742.43 | 180 / 180 | 93% | 62.70 | 399 / 430 |
| skin | 90% | 11660.47 | 1634 / 1809 | 94% | 157.80 | 444 / 472 |
| bladder | 100% | 3949.29 | 21 / 21 | 83% | 48.37 | 420 / 504 |
| uterus | 100% | 7975.26 | 170 / 170 | 79% | 104.38 | 362 / 459 |
| adrenal gland | 100% | 4055.50 | 258 / 258 | 76% | 127.78 | 174 / 230 |
| thymus | 99% | 4674.95 | 649 / 653 | 74% | 25.97 | 447 / 605 |
| liver | 92% | 2516.88 | 207 / 226 | 72% | 40.56 | 291 / 406 |
| intestine | 79% | 2382.87 | 765 / 966 | 83% | 38.65 | 437 / 527 |
| kidney | 85% | 2382.79 | 76 / 89 | 72% | 26.21 | 651 / 901 |
| esophagus | 72% | 1896.91 | 1039 / 1445 | 83% | 38.82 | 151 / 183 |
| stomach | 59% | 1605.65 | 212 / 359 | 85% | 37.57 | 242 / 286 |
| pancreas | 46% | 773.03 | 151 / 328 | 94% | 92.71 | 168 / 178 |
| lymph node | 0% | 0 | 0 / 0 | 100% | 49.18 | 29 / 29 |
| ureter | 0% | 0 | 0 / 0 | 100% | 20.37 | 1 / 1 |
| adipose | 99% | 6838.81 | 1188 / 1204 | 0% | 0 | 0 / 0 |
| blood vessel | 96% | 5181.57 | 1277 / 1335 | 0% | 0 | 0 / 0 |
| heart | 94% | 4349.19 | 812 / 861 | 0% | 0 | 0 / 0 |
| spleen | 85% | 1526.95 | 206 / 241 | 0% | 0 | 0 / 0 |
| tonsil | 0% | 0 | 0 / 0 | 76% | 32.34 | 34 / 45 |
| brain | 17% | 295.71 | 455 / 2642 | 39% | 25.98 | 277 / 705 |
| eye | 0% | 0 | 0 / 0 | 40% | 10.48 | 32 / 80 |
| muscle | 19% | 308.83 | 152 / 803 | 0% | 0 | 0 / 0 |
| peripheral blood | 0% | 2.25 | 2 / 929 | 0% | 0 | 0 / 0 |
| abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| GO_0006508 | Biological process | proteolysis |
| GO_0032964 | Biological process | collagen biosynthetic process |
| GO_0005615 | Cellular component | extracellular space |
| GO_0070062 | Cellular component | extracellular exosome |
| GO_0005576 | Cellular component | extracellular region |
| GO_0062023 | Cellular component | collagen-containing extracellular matrix |
| GO_0005201 | Molecular function | extracellular matrix structural constituent |
| GO_0008201 | Molecular function | heparin binding |
| GO_0005518 | Molecular function | collagen binding |
| GO_0005515 | Molecular function | protein binding |
| GO_0016504 | Molecular function | peptidase activator activity |
| Gene name | PCOLCE |
| Protein name | Procollagen C-endopeptidase enhancer Procollagen C-endopeptidase enhancer 1 (Procollagen COOH-terminal proteinase enhancer 1) (PCPE-1) (Procollagen C-proteinase enhancer 1) (Type 1 procollagen C-proteinase enhancer protein) (Type I procollagen COOH-terminal proteinase enhancer) |
| Synonyms | tcag7.602 PCPE1 |
| Description | FUNCTION: Binds to the C-terminal propeptide of type I procollagen and enhances procollagen C-proteinase activity.; FUNCTION: C-terminal processed part of PCPE (CT-PCPE) may have an metalloproteinase inhibitory activity. |
| Accessions | A4D2D2 Q15113 ENST00000223061.6 |
